FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
Ryan Allway May 10th, 2022 Psychedelics, Top News Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50 million or approximately CAD $1.30 per share with only 38.4 million shares issued Profit realized on the sale of the non-core asset which was acquired by FSD Pharma in... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )